Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: Comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays

Journal of Infectious Diseases

Volumn 193, Issue 2, 2006, Pages 287-297

  Tierney, Rosemary J ^a   Edwards, Rachel Hood ^b   Sitki Green, Diane ^b,c   Croom Carter, Deborah ^a   Roy, Sushmita ^a,d   Yao, Qing Yun ^a   Raab Traub, Nancy ^b   Rickinson, Alan B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 2; LATENT MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; DNA SEQUENCE; EPSTEIN BARR VIRUS; HETERODUPLEX ANALYSIS; HETERODUPLEX TRACKING ASSAY; INFECTIOUS MONONUCLEOSIS; LYMPHOCYTE TRANSFORMATION; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; THROAT; VIRUS INFECTION; VIRUS ISOLATION; VIRUS STRAIN;

BLOOD; DNA, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; INFECTIOUS MONONUCLEOSIS; NUCLEIC ACID HETERODUPLEXES; NUCLEIC ACID HYBRIDIZATION; PHARYNX; VIRAL MATRIX PROTEINS;

EID: 30944437416     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/498913     Document Type: Article

References (35)

1. Dambaugh T, Hennessy K, Chamnankit L, Kieff E. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 1984; 81:7632-6.
2. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 1990; 64:4084-92.
3. Aitken C, Sengupta SK, Aedes C, Moss DJ, Sculley TB. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. J Gen Virol 1994; 75:95-100.
4. Habeshaw G, Yao QY, Bell AI, Morton D, Rickinson AB. Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. J Virol 1999; 73:965-75.
5. Miller WE, Edwards RH, Walling DM, Raab-Traub N. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol 1994; 75:2729-40.
6. Schuster V, Ott G, Seidenspinner S, Kreth HW. Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV-associated disorders. Blood 1996; 87:1579-85.
7. Snudden DK, Smith PR, Lai D, Ng MH, Griffin BE. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial-cell tumors. Oncogene 1995; 10:1545-52.
8. Sung NS, Edwards RH, Seillier-Moiseiwitsch F, Perkins AG, Zeng Y, Raab-Traub N. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int J Cancer 1998; 76:207-15.
9. Wrightham MN, Stewart JP, Janjua NJ, et al. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr-virus nuclear antigen EBNA-1. Virology 1995; 208:521-30.
10. Gratama JW, Oosterveer MA, Weimar W, et al. Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. J Gen Virol 1994; 75:85-94.
11. Yao QY, Rowe M, Martin B, Young LS, Rickinson AB. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J Gen Virol 1991; 72:1579-90.
12. Yao QY, Croom-Carter DS, Tierney RJ, et al. Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort. J Virol 1998; 72: 4352-63.
13. van Baarle D, Hovenkamp E, Dukers NH, et al. High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission. J Infect Dis 2000; 181:2045-9.
14. Sculley TB, Apolloni A, Hurren L, Moss DJ, Cooper DA. Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis 1990; 162:643-8.
15. Yao QY, Tierney RJ, Croom-Carter D, et al. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J Virol 1996; 70:4884-94.
16. Rickinson AB, Young LS, Rowe M. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 1987; 61:1310-7.
17. Apolloni A, Sculley TB. Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology 1994; 202:978-81.
18. Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L. Detection of a second widespread strain of Epstein-Barr virus. Lancet 1989; 2: 761-5.
19. Correa RM, Fellner MD, Alonio LV, Durand K, Teyssie AR, Picconi MA. Epstein-barr virus (EBV) in healthy carriers: distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene. J Med Virol 2004; 73:583-8.
20. Plaza G, Santon A, Bellas C. Coinfection by multiple strains of Epstein-Barr virus in infectious mononucleosis in immunocompetent patients. Acta Otolaryngol 2003; 123:543-6.
21. Sitki-Green D, Covington M, Raab-Traub N. Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J Virol 2003; 77:1840-7.
22. Sitki-Green DL, Edwards RH, Covington MM, Raab-Traub N. Biology of Epstein-Barr virus during infectious mononucleosis. J Infect Dis 2004; 189:483-92.
23. Kerr BM, Kienzle N, Burrows JM, et al. Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus. J Virol 1996; 70:8858-64.
24. + T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med 2002; 195:893-905.
25. Sitki-Green D, Edwards RH, Webster-Cyriaque J, Raab-Traub N. Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay. J Virol 2002; 76:9645-56.
26. Walling DM, Perkins AG, Webster-Cyriaque J, et al. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. J Virol 1994; 68:7918-26.
27. Khanim F, Yao QY, Niedobitek G, Sihota S, Rickinson AB, Young LS. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996; 88:3491-501.
28. Brooks JM, Croom-Carter DS, Leese AM, Tierney RJ, Habeshaw G, Rickinson AB. Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains. J Virol 2000; 74:1801-9.
29. Falk KI, Zou JZ, Lucht E, Linde A, Ernberg I. Direct identification by PCR of EBV types and variants in clinical samples. J Med Virol 1997;51: 355-63.
30. Kunimoto M, Tamura S, Tabata T, Yoshie O. One-step typing of Epstein-Barr virus by polymerase chain reaction: predominance of type 1 virus in Japan. J Gen Virol 1992; 73:455-61.
31. Buisson M, Morand P, Genoulaz O, Bourgeat MJ, Micoud M, Seigneurin JM. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. J Gen Virol 1994; 75:431-7.
32. Luxton JC, Williams I, Weller I, Crawford DH. Epstein-Barr virus infection of HIV-seropositive individuals is transiently suppressed by high-dose acyclovir treatment. AIDS 1993; 7:1337-43.
33. Gutierrez MI, Bhatia K, Cherney B, Capello D, Gaidano G, Magrath I. Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma. Ann Oncol 1997; 8:987-94.
34. Gutierrez MI, Spangler G, Kingma D, et al. Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene. Blood 1998; 92:600-6.
35. Edwards RH, Seillier-Moiseiwitsch F, Raab-Traub N. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology 1999; 261:79-95.